161 related articles for article (PubMed ID: 337156)
1. Historical background of the National Cancer Institute's drug development thrust.
Zubrod CG; Schepartz SA; Carter SK
Natl Cancer Inst Monogr; 1977 Mar; (45):7-11. PubMed ID: 337156
[No Abstract] [Full Text] [Related]
2. The NCI Developmental Therapeutics Program.
Collins JM
Clin Adv Hematol Oncol; 2006 Apr; 4(4):271-3. PubMed ID: 16728938
[No Abstract] [Full Text] [Related]
3. The National Cancer Institute's Drug Development Program.
Schepartz SA
Prog Clin Biol Res; 1985; 197():73-82. PubMed ID: 4070301
[No Abstract] [Full Text] [Related]
4. Natural product drug discovery and development: the United States National Cancer Institute role.
Cragg GM
P R Health Sci J; 2002 Jun; 21(2):97-111. PubMed ID: 12166031
[No Abstract] [Full Text] [Related]
5. Clinical development of anticancer agents--a National Cancer Institute perspective.
Marsoni S; Wittes R
Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
[No Abstract] [Full Text] [Related]
6. Molecular biology. Universities join the screening bandwagon.
Kaiser J
Science; 2008 Aug; 321(5890):766. PubMed ID: 18687935
[No Abstract] [Full Text] [Related]
7. Screening at the National Cancer Institute.
Goldin A; Venditti JM; Carter SK
Natl Cancer Inst Monogr; 1977 Mar; (45):37-48. PubMed ID: 337155
[No Abstract] [Full Text] [Related]
8. Molecular biology. Industrial-style screening meets academic biology.
Kaiser J
Science; 2008 Aug; 321(5890):764-6. PubMed ID: 18687934
[No Abstract] [Full Text] [Related]
9. Anticancer drug development at the US National Cancer Institute.
Takimoto CH
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S29-33. PubMed ID: 12819935
[TBL] [Abstract][Full Text] [Related]
10. In the middle: 1954---63--historical note.
Shimkin MB
J Natl Cancer Inst; 1979 May; 62(5):1295-317. PubMed ID: 220451
[No Abstract] [Full Text] [Related]
11. The historical development of cancer chemotherapy.
Burchenal JH
Semin Oncol; 1977 Jun; 4(2):135-46. PubMed ID: 327552
[No Abstract] [Full Text] [Related]
12. Cancer research program strategy and planning--the use of contracts for program implementation.
Baker CG
J Natl Cancer Inst; 1977 Aug; 59(2 Suppl):651-69. PubMed ID: 328910
[No Abstract] [Full Text] [Related]
13. Origins and development of chemotherapy research at the National Cancer Institute.
Zubrod CG
Cancer Treat Rep; 1984 Jan; 68(1):9-19. PubMed ID: 6362871
[No Abstract] [Full Text] [Related]
14. The linear array.
Zubrod CG; Schepartz SA; Carter SK
Natl Cancer Inst Monogr; 1977 Mar; (45):13-4. PubMed ID: 927488
[No Abstract] [Full Text] [Related]
15. As memory serves--an informal history of the National Cancer Institute, 1937-57.
Shimkin MB
J Natl Cancer Inst; 1977 Aug; 59(2 Suppl):559-600. PubMed ID: 328903
[No Abstract] [Full Text] [Related]
16. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
DeWys WD; Greenwald P
Semin Oncol; 1983 Sep; 10(3):360-4. PubMed ID: 6665563
[No Abstract] [Full Text] [Related]
17. Advances in the clinical development of antiepileptic drugs.
Porter RJ; Hessie BJ; Cereghino JJ; Gladding GD; Kupferberg HJ; Scoville B; White BG
Fed Proc; 1985 Jul; 44(10):2645-9. PubMed ID: 3891417
[TBL] [Abstract][Full Text] [Related]
18. The National Cancer Institute's Special Populations Networks for cancer awareness, research, and training.
Clanton M
Cancer; 2006 Oct; 107(8 Suppl):1931-2. PubMed ID: 16958025
[No Abstract] [Full Text] [Related]
19. Cancer and AIDS: National Cancer Institute's investment in research.
Feigal EG; Black JB
Res Initiat Treat Action; 2003; 9(1):26-9. PubMed ID: 14971363
[No Abstract] [Full Text] [Related]
20. Experimental evaluation of antitumor drugs in the USA and USSR and clinical correlations.
Natl Cancer Inst Monogr; 1980 Dec; (55):1-179. PubMed ID: 7010179
[No Abstract] [Full Text] [Related]
[Next] [New Search]
